IGFBP7 binds to the IGF-1 receptor and blocks its activation by insulin-like growth factors von Evdokimova, Valentina, Tognon, Cristina E, Benatar, Tania, Yang, Wenyi, Krutikov, Konstantin, Pollak, Michael, Sorensen, Poul H B, Seth, Arun

Volltext

MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence von Nam, Robert K., Benatar, Tania, Wallis, Christopher J. D., Amemiya, Yutaka, Yang, Wenyi, Garbens, Alaina, Naeim, Magda, Sherman, Christopher, Sugar, Linda, Seth, Arun

Volltext

IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways von Benatar, Tania, Yang, Wenyi, Amemiya, Yutaka, Evdokimova, Valentina, Kahn, Harriette, Holloway, Claire, Seth, Arun

Volltext

MicroRNA-652 induces NED in LNCaP and EMT in PC3 prostate cancer cells von Nam, Robert K, Benatar, Tania, Amemiya, Yutaka, Wallis, Christopher J D, Romero, Joan Miguel, Tsagaris, Melina, Sherman, Christopher, Sugar, Linda, Seth, Arun

Volltext

IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo von Benatar, Tania, Cao, Ming Y, Lee, Yoon, Lightfoot, Jeff, Feng, Ningping, Gu, Xiaoping, Lee, Vivian, Jin, Hongnan, Wang, Ming, Wright, Jim A, Young, Aiping H

Volltext

347 Functional characterization of GUCY2C-TAC T cells for the treatment of colorectal cancer using preclinical models von Benatar, Tania, Nitya-Nootan, Thanyashanthi, Thakor, Gargi, Prosser, Suzanna L, Ip, Philbert, Lal, Prabha, Khan, Alima, Xu, Stacey X, Pirati, Sailaja, Bhemarasetty, Deepika, Helsen, Christopher W, Bader, Andreas G

Volltext

118 Development of Claudin 18.2 TAC T cells for the treatment of gastric cancer von Helsen, Christopher, Benatar, Tania, Philbert, IP, Xu, Stacey, Shaver, Laura, Nitya-Nootan, Thanyashanthi, Bader, Andreas, Lal, Prabha

Volltext

Ligand/Receptor Signaling Threshold (LIST) Model Accounts for gp130‐Mediated Embryonic Stem Cell Self‐Renewal Responses to LIF and HIL‐6 von Viswanathan, Sowmya, Benatar, Tania, Rose‐John, Stefan, Lauffenburger, Doug A., Zandstra, Peter W.

Volltext

Abstract 276: Mir-139 regulates autophagy in prostate cancer cells through Beclin-1 and mTOR signaling proteins von Benatar, Tania C., Nam, Robert, Sherman, Christopher, Amemiya, Yutaka, Seth, Arun

Volltext

Supplementation-dependent differences in the rates of embryonic stem cell self-renewal, differentiation, and apoptosis von Viswanathan, Sowmya, Benatar, Tania, Mileikovsky, Maria, Lauffenburger, Douglas A., Nagy, Andras, Zandstra, Peter W.

Volltext

MicroRNA‐139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXL von Nam, Robert K., Benatar, Tania, Wallis, Christopher J. D., Kobylecky, Elizabeth, Amemiya, Yutaka, Sherman, Christopher, Seth, Arun

Volltext

MiR-139 Induces an Interferon-beta Response in Prostate Cancer Cells by Binding to RIG-1 von Nam, Robert K., Benatar, Tania, Amemiya, Yutaka, Seth, Arun

Volltext

Abstract 3554: miR-139 is associated with improved prognosis in patients with localized prostate cancer von Benatar, Tania, Nam, Robert K., Kobylecky, Elizabeth, Amemiya, Yutaka, Seth, Arun K.

Volltext

Identification of a Novel MicroRNA Panel Associated with Metastasis Following Radical Prostatectomy for Prostate Cancer von Nam, Robert K, Wallis, Christopher J D, Amemiya, Yutaka, Benatar, Tania, Seth, Arun

Volltext

Abstract 2522: MiRNA-652 induces neuroendocrine-like differentiation in LNCaP prostate cancer cells through decreased PP2A function von Benatar, Tania, Amemiya, Yutaka, Wallis, Christopher J., Sugar, Linda, Sherman, Christopher, Nam, Robert, Seth, Arun K.

Volltext

Abstract A079: MicroRNA-139 regulates prostate cancer aggressiveness by targeting IGF1R von Amemiya, Yutaka, Wallis, Christopher J., Benatar, Tania, Kobylecky, Elizabeth, Sugar, Linda, Sherman, Christopher, Nam, Robert, Seth, Arun K.

Volltext

Abstract 2249: N- and C-terminal peptides of the tumor suppressor protein IGFBP7 differentially induce growth arrest or senescence in breast cancer cells von Benatar, Tania C., Amemiya, Yutaka, Evdokimova, Valentina, Yang, Wenyi, Seth, Arun

Volltext

294 Preclinical studies of TAC01-CLDN18.2, an autologous claudin 18.2-directed TAC T cell therapy, in the treatment of gastric cancer von Wang, Ling, Xu, Stacey, Benatar, Tania, Prosser, Suzanna, Shaver, Laura, Randhawa, Ritu, Ip, Philbert, Lal, Prabha, Nitya-Nootan, Thanyashanthi, MacGregor, Heather, Sengupta, Sadhak, Helsen, Christopher, Bader, Andreas

Volltext

Abstract 572: Pre-clinical evaluation of Claudin 18.2 TAC T cells for the treatment of gastric cancer von Benatar, Tania, Wang, Ling, Nitya-Nootan, Thanyashanthi, MacGregor, Heather, Prosser, Suzanna, Ip, Philbert, Lal, Prabha, Shaver, Laura, Sengupta, Sadhak, Helsen, Christopher W., Bader, Andreas G.

Volltext

Abstract 3188: Patient-derived TAC01-HER2 TAC T cells produced in Cocoon® Platform is highly functional in models of solid tumors von Wang, Ling, Xu, Stacey X., Benatar, Tania, Randhawa, Ritu R., Ip, Philbert, Lal, Prabha, Nitya-Nootan, Thanyashanthi, Ravensbergen, Laura, MacGregor, Heather, Prosser, Suzy, Sengupta, Sadhak, Helsen, Christopher W., Bader, Andreas G.

Volltext